Wednesday, June 10, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 26 of 1,261
  1. US 12371414

    Methods of treating neurological disorders

    Neumora Therapeutics, Inc. Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  2. US 12370232

    Use of polyphenol containing sugar cane extracts for preventing, improving or treating a skin condition

    Poly Gain Pte Ltd Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  3. US 12370261

    Chimeric peptides for antisense delivery

    Sarepta Therapeutics, Inc. Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  4. US 12370196

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  5. US 12370229

    Methods of treating bladder cancer

    CG ONCOLOGY, INC. Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  6. US 12370245

    ALK polypeptides and methods of use thereof

    Elicio Therapeutics, Inc. Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  7. US 12370206

    Therapy for inhibition of single-stranded RNA virus replication

    RedHill Biopharma Ltd. Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  8. US 12370142

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  9. US 12370255

    Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  10. US 12370270

    Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders

    The Regents of the University of California Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  11. US 12371420

    Polymorphs of Selinexor

    Karyopharm Therapeutics Inc. Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  12. US 12370266

    Polymer composite nanomaterial encapsulation system

    Core Quantum, Inc. Β· Granted Jul 29, 2025 Β· Expires Jul 24, 2045

    granted
  13. US 2025235515

    CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS AND IMPROVED DRYING PROCESSES

    ABBVIE INC [US] Β· Granted Jul 24, 2025 Β· Expires Jul 19, 2045

    granted
  14. WO 2025153663

    LANDIOLOL COMPLEXÉ ENCAPSULÉ OU DISSOUS DANS UNE MATRICE LIPOPHILE

    AOP ORPHAN PHARMACEUTICALS GMBH [AT] Β· Granted Jul 24, 2025 Β· Expires Jul 19, 2045

    granted
  15. US 12364717

    Compositions and methods for inhibiting seizures

    The Regents of the University of California Β· Granted Jul 22, 2025 Β· Expires Jul 17, 2045

    granted
  16. US 12364671

    Methods of administering vitamin A and lactic acid to gilts

    China Agricultural University Β· Granted Jul 22, 2025 Β· Expires Jul 17, 2045

    granted
  17. US 12365761

    Biodegradable ultra-pH sensitive polymers

    The Board of Regents of the University of Texas System Β· Granted Jul 22, 2025 Β· Expires Jul 17, 2045

    granted
  18. US 12364736

    Methods for treating heterotopic ossification

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Jul 22, 2025 Β· Expires Jul 17, 2045

    granted
  19. US 12364753

    CD8 binding agents

    Orionis Biosciences, Inc Β· Granted Jul 22, 2025 Β· Expires Jul 17, 2045

    granted
  20. US 12364708

    Injectable scaffold for treatment of intracranial aneurysms and related technology

    Covidien LP Β· Granted Jul 22, 2025 Β· Expires Jul 17, 2045

    granted
  21. US 12364668

    Treatment of opioid use disorder, opioid withdrawal symptoms, and chronic pain

    The Regents of the University of California Β· Granted Jul 22, 2025 Β· Expires Jul 17, 2045

    granted
  22. US 12364680

    Compounds for treating ophthalmic diseases and disorders

    KIORA PHARMACEUTICALS GmbH Β· Granted Jul 22, 2025 Β· Expires Jul 17, 2045

    granted
  23. US 12365930

    Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates

    Northwestern University Β· Granted Jul 22, 2025 Β· Expires Jul 17, 2045

    granted
  24. US 12364737

    Activin receptor type IIA variants and methods of use thereof

    Keros Therapeutics, Inc. Β· Granted Jul 22, 2025 Β· Expires Jul 17, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.